PREDICTIMMUNE
PredictImmune is developing pioneering tools for guiding treatment options in immune-mediated inflammatory diseases with the first product addressing Inflammatory Bowel Disease (both Crohn’s and ulcerative colitis). Based on world-leading research at Cambridge University, UK, they are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payors all recognise the value of such an approach to the management of Inflammatory Bowel Disease.
PREDICTIMMUNE
Industry:
Biopharma Biotechnology Health Care Life Science Medical Medical Device
Founded:
2017-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.predictimmune.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)1223 804 195
Email Addresses:
[email protected]
Total Funding:
31.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Parkwalk Advisors
Parkwalk Advisors investment in Series A - PredictImmune
Parkwalk Advisors
Parkwalk Advisors investment in Series B - PredictImmune
Cambridge Innovation Capital
Cambridge Innovation Capital investment in Series B - PredictImmune
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series B - PredictImmune
Business Growth Fund
Business Growth Fund investment in Series B - PredictImmune
Innovate UK
Innovate UK investment in Grant - PredictImmune
Wellcome Trust
Wellcome Trust investment in Grant - PredictImmune
Parkwalk Advisors
Parkwalk Advisors investment in Series A - PredictImmune
Wren Capital
Wren Capital investment in Series A - PredictImmune
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Series A - PredictImmune
Official Site Inspections
http://www.predictimmune.com Semrush global rank: 5.34 M Semrush visits lastest month: 1.56 K
- Host name: 192.64.119.79
- IP address: 192.64.119.79
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064